Israeli study finds 94% drop in symptomatic COVID-19 cases with Pfizer vaccine | Reuters
Description
Israel's largest healthcare provider on Sunday reported a 94% drop in symptomatic COVID-19 infections among 600,000 people who received two doses of the Pfizer's vaccine in the country's biggest study to date.
Please update your browser to visit this Perma Link.
Perma.cc has been tested with the latest version of:
Google Chrome, Mozilla Firefox, Apple Safari and Microsoft Edge.